Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
We break down expense ratios across popular index funds and show how choosing the lowest-cost options can improve long-term retirement outcomes.
28,023 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
The Postal Service is weighing a rule that could allow concealable firearms to be mailed. The move has drawn a DOJ-su...
Pi Network’s PI tumbled to fresh lows as crypto markets slid, prompting a debate over whether the drop signals a quic...
XRP sits near $1 as macro caution weighs on crypto. Analysts debate whether Ripple can spark a breakout in 2026, with...
Axon is set to report Q4 2025 results after the close, as Wall Street weighs software momentum, AI-era bookings, and ...
Ethereum is forming a potential base after a sharp February selloff, with key support holding around $1,800-$1,700. A...
Alphabet is tightening the gap with Nvidia as AI wins bolster its diversified business empire. Investors weigh the im...
A key borrower suit against loanDepot faces a leadership shift after the plaintiffs’ attorney offers exit amid confli...
Adobe stock is staging a comeback after a brutal selloff, with stronger earnings and AI-driven growth fueling optimis...
Snap lies close to $5 as its paid Snapchat+ service fuels ongoing revenue growth. With 25 million subscribers and a $...
Markets tilt away from AI hype toward real-world assets as the Great Rotation accelerates. TerraTread debuts a durabl...
Hundreds of families in Guerrero have fled their homes after a cartel armed with drones attacked rural communities, t...